Efficacy of Pulsed Electromagnetic Field Therapy on Women With Endometriosis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-45
SponsorBeni-Suef University
About this trial
This randomized, sham-controlled, double-blinded clinical trial aims to investigate the effects of pulsed electromagnetic field therapy (PEMF) on pain intensity, quality of life, and pelvic floor morphometric changes assessed by four-dimensional trans perineal ultrasound (4D TPUS) in women diagnosed with endometriosis. Participants will be randomly allocated into either a PEMF therapy group or a sham PEMF control group. Both groups will continue receiving stable standard medical care throughout the study period. Assessments will be conducted at baseline, after completion of the 8-week intervention period, and at 3-month follow-up.
Eligibility criteria
Qualifiers
Women aged 18 to 45 years
Clinically, radiologically, or laparoscopically diagnosed endometriosis
Chronic pelvic pain persisting for at least 6 months
Stable pharmacological or hormonal treatment for at least 3 months before enrollment
Disqualifiers
Pregnancy or planned pregnancy during the study period
History of gynecological or pelvic malignancy
Active pelvic inflammatory disease or acute pelvic infection
Implanted electronic medical devices such as pacemakers or neurostimulators
Trial design
Treatments tested in this trial
- Pulsed Electromagnetic Field Therapy
- Sham pulsed electromagnetic field therapy
Treatment groups
60 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov